Vitamin D controls T cell antigen receptor signaling and activation of human T cells - PubMed (original) (raw)
doi: 10.1038/ni.1851. Epub 2010 Mar 7.
Affiliations
- PMID: 20208539
- DOI: 10.1038/ni.1851
Vitamin D controls T cell antigen receptor signaling and activation of human T cells
Marina Rode von Essen et al. Nat Immunol. 2010 Apr.
Abstract
Phospholipase C (PLC) isozymes are key signaling proteins downstream of many extracellular stimuli. Here we show that naive human T cells had very low expression of PLC-gamma1 and that this correlated with low T cell antigen receptor (TCR) responsiveness in naive T cells. However, TCR triggering led to an upregulation of approximately 75-fold in PLC-gamma1 expression, which correlated with greater TCR responsiveness. Induction of PLC-gamma1 was dependent on vitamin D and expression of the vitamin D receptor (VDR). Naive T cells did not express VDR, but VDR expression was induced by TCR signaling via the alternative mitogen-activated protein kinase p38 pathway. Thus, initial TCR signaling via p38 leads to successive induction of VDR and PLC-gamma1, which are required for subsequent classical TCR signaling and T cell activation.
Comment in
- Control of T cell activation by vitamin D.
Smolders J, Thewissen M, Damoiseaux J. Smolders J, et al. Nat Immunol. 2011 Jan;12(1):3; author reply 3-4. doi: 10.1038/ni0111-3a. Nat Immunol. 2011. PMID: 21169995 No abstract available.
Similar articles
- 1,25(OH)2D3 induces regulatory T cell differentiation by influencing the VDR/PLC-γ1/TGF-β1/pathway.
Zhou Q, Qin S, Zhang J, Zhon L, Pen Z, Xing T. Zhou Q, et al. Mol Immunol. 2017 Nov;91:156-164. doi: 10.1016/j.molimm.2017.09.006. Epub 2017 Sep 17. Mol Immunol. 2017. PMID: 28926770 - Control of T cell activation by vitamin D.
Smolders J, Thewissen M, Damoiseaux J. Smolders J, et al. Nat Immunol. 2011 Jan;12(1):3; author reply 3-4. doi: 10.1038/ni0111-3a. Nat Immunol. 2011. PMID: 21169995 No abstract available. - Stromal cell-derived factor-1 signaling via the CXCR4-TCR heterodimer requires phospholipase C-β3 and phospholipase C-γ1 for distinct cellular responses.
Kremer KN, Clift IC, Miamen AG, Bamidele AO, Qian NX, Humphreys TD, Hedin KE. Kremer KN, et al. J Immunol. 2011 Aug 1;187(3):1440-7. doi: 10.4049/jimmunol.1100820. Epub 2011 Jun 24. J Immunol. 2011. PMID: 21705626 Free PMC article. - LAT, the linker for activation of T cells: a bridge between T cell-specific and general signaling pathways.
Wange RL. Wange RL. Sci STKE. 2000 Dec 19;2000(63):re1. doi: 10.1126/stke.2000.63.re1. Sci STKE. 2000. PMID: 11752630 Review. - Keeping the (kinase) party going: SLP-76 and ITK dance to the beat.
Qi Q, August A. Qi Q, et al. Sci STKE. 2007 Jul 24;2007(396):pe39. doi: 10.1126/stke.3962007pe39. Sci STKE. 2007. PMID: 17652306 Free PMC article. Review.
Cited by
- Metabolic mediators: microbial-derived metabolites as key regulators of anti-tumor immunity, immunotherapy, and chemotherapy.
Lu S, Wang C, Ma J, Wang Y. Lu S, et al. Front Immunol. 2024 Sep 16;15:1456030. doi: 10.3389/fimmu.2024.1456030. eCollection 2024. Front Immunol. 2024. PMID: 39351241 Free PMC article. Review. - Contemporary Perspectives on the Role of Vitamin D in Enhancing Gut Health and Its Implications for Preventing and Managing Intestinal Diseases.
Wang J, Mei L, Hao Y, Xu Y, Yang Q, Dai Z, Yang Y, Wu Z, Ji Y. Wang J, et al. Nutrients. 2024 Jul 20;16(14):2352. doi: 10.3390/nu16142352. Nutrients. 2024. PMID: 39064795 Free PMC article. Review. - Vitamin D and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Novel Mechanistic Insights.
Aggeletopoulou I, Tsounis EP, Triantos C. Aggeletopoulou I, et al. Int J Mol Sci. 2024 Apr 30;25(9):4901. doi: 10.3390/ijms25094901. Int J Mol Sci. 2024. PMID: 38732118 Free PMC article. Review. - Vitamin D in Cutaneous T-Cell Lymphoma.
Ødum AF, Geisler C. Ødum AF, et al. Cells. 2024 Mar 13;13(6):503. doi: 10.3390/cells13060503. Cells. 2024. PMID: 38534347 Free PMC article. Review. - Modulation of the vitamin D receptor by traditional Chinese medicines and bioactive compounds: potential therapeutic applications in VDR-dependent diseases.
Yao M, Oduro PK, Akintibu AM, Yan H. Yao M, et al. Front Pharmacol. 2024 Jan 22;15:1298181. doi: 10.3389/fphar.2024.1298181. eCollection 2024. Front Pharmacol. 2024. PMID: 38318147 Free PMC article. Review.
References
- Nat Immunol. 2007 Mar;8(3):285-93 - PubMed
- Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20834-9 - PubMed
- Annu Rev Pharmacol Toxicol. 2006;46:355-79 - PubMed
- Scand J Immunol. 1988 Jun;27(6):685-96 - PubMed
- Proc Natl Acad Sci U S A. 2008 Apr 1;105(13):5207-12 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous